MFN1 augmentation prevents retinal degeneration in a Charcot-Marie-Tooth type 2A mouse model

Keyphrases

• Mouse Model 100%
• Charcot-Marie-Tooth Disease 100%
• Retinal Degeneration 100%
• Mfn1 100%
• Mitofusin 2 (Mfn2) 80%
• Retina 40%
• Mitophagy 40%
• Transgenic 20%
• Synaptic 20%
• Homeostasis 20%
• Retinal Ganglion Cells 20%
• Vision Loss 20%
• Dysregulated 20%
• Transgenic Mouse Model 20%
• Parkin 20%
• Morphological Changes 20%
• Functional Change 20%
• Visual Acuity 20%
• Gliosis 20%
• Autophagy 20%
• Color Blindness 20%
• Mitochondrial Fission 20%
• Photoreceptor Degeneration 20%
• Fission-fusion 20%
• Dominant mutation 20%
• Axonal Loss 20%
• Axonal Neuropathy 20%
• Sensory Loss 20%
• Retinal Morphology 20%
• Motor Loss 20%
• LC3B 20%

Medicine and Dentistry

• DeJerine-Sottas Disease 100%
• Retina Degeneration 100%
• Mitophagy 66%
• Transgenic Mouse 33%
• Homeostasis 33%
• Visual Impairment 33%
• Morphology 33%
• Autophagy 33%
• Visual Acuity 33%
• Neuropathy 33%
• Gliosis 33%
• Color Vision Defect 33%
• Parkin 33%
• Mitochondrial Fusion 33%
• Ganglion 33%
• Photoreceptor 33%